Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
Marta López-Fauqued,L. Cámpora,51 Authors,T. Zahaf
2019 · DOI: 10.1016/j.vaccine.2019.03.043
Vaccine · 53 Citations
TLDR
Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.